Quick Answer
SUTRO BIOPHARMA, INC. reported Net Income of -$191.09 million for fiscal year 2025.
SUTRO BIOPHARMA, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$191.09M | +16.0% |
| 2024 | -$227.46M | -113.0% |
| 2023 | -$106.79M | +10.4% |
| 2022 | -$119.20M | -12.9% |
| 2021 | -$105.54M | -228.5% |
| 2020 | -$32.13M | +73.0% |
| 2019 | -$119.20M | -237.5% |
| 2018 | -$35.32M | -79.4% |
| 2017 | -$19.69M | -1256.8% |
| 2016 | $1.70M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$56.86M | -16.5% | -394.5% |
| June 30, 2025 | -$11.50M | +76.1% | +84.9% |
| March 31, 2025 | -$75.97M | -30.5% | -55.7% |
| September 30, 2024 | -$48.79M | +1.0% | -1.6% |
| June 30, 2024 | -$48.02M | -24.6% | +17.5% |
| March 31, 2024 | -$58.21M | -16.3% | -18.1% |
| September 30, 2023 | -$49.28M | -152.9% | -27.9% |
| June 30, 2023 | -$38.52M | -48.1% | +23.0% |
- SUTRO BIOPHARMA, INC. showed an increase of +16.0% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, SUTRO BIOPHARMA, INC.’s net income has declined by 11327.1% (from $1.70 million to -$191.09 million).
- The most recent figure is from SUTRO BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: